October 28, 2008--CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ: IVGN) today announced that its shareholders have voted to approve the company's proposed merger with Applied ...

Invitrogen Corporation (NASDAQ: IVGN) and Applera Corporation today announced that their Boards of Directors have approved a definitive merger agreement, under which Invitrogen will acquire all of the ...

This presentation will provide an overview of two new Invitrogen data analysis software apps available on the Thermo Fisher™ Connect Platform to analyze data acquired on Luminex® xMAP instruments. The ...

Aga2-fusion protein binding to yeast cell by Aga1. Image provided by Invitrogen. Phage display systems, reviewed in a recent issue of The Scientist, 1 have proven enormously useful for the detection ...

Invitrogen (www.invitrogen.com), supplier of reagents and tools for gene and protein research for 20 years, is expanding its product lines and moving toward cell biology. In the past few years, ...

In 1987, three local researchers gathered in an Encinitas garage with an idea that, 26 years later, is worth $13.6 billion. The garage belonged to Lyle Turner, who got together with partners Joe ...

From a solo flight around the world in his single-engine plane to starting a foundation that protects endangered coral reefs, Lyle Turner has seldom sat still in the decade since he retired from ...

Accurate and efficient data analysis of protein targets is an integral part of the gel and western blot imaging workflow. The Invitrogen iBright Analysis Software is an optimized software application ...

President and COO of Applied Biosystems Answers GEN’s Questions about the Merger I recently attended a press event where the joint venture between Applied Biosystems (AB) /MDS Analytical Technologies ...

The company created by the merger, expected to close this fall pending regulatory and shareholder approval, will retain the Applied Biosystems name while operating out of Invitrogen's Carlsbad, CA ...

Invitrogen Corporation has announced the acquisitions of Quantum Dot Corporation and the BioPixels® business unit of BioCrystal, Ltd. and the early closing of the Biosource International, Inc.

SAN FRANCISCO (MarketWatch) -- Invitrogen Corp. said after the closing bell on Tuesday that James Glynn, chief executive officer emeritus, plans to retire as a director at the annual shareholder ...